CNS Pharmaceuticals, Inc. (CNSP)

NASDAQ: CNSP · IEX Real-Time Price · USD

1.260

-0.160 (-11.27%)

At close: Jul 2, 2024, 4:00 PM

1.280

+0.020 (1.59%)

After-hours: Jul 2, 2024, 7:56 PM EDT

CNS Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	0	7	3	20	30	65	Upgrade
Market Cap Growth	1.05%	108.14%	-83.67%	-33.84%	-54.38%	-	Upgrade
Enterprise Value	-0	6	-6	15	16	58	Upgrade
PE Ratio	-	-0.35	-0.21	-1.35	-3.13	-16.76	Upgrade
PB Ratio	-0.51	-1.50	0.39	3.18	2.13	8.55	Upgrade
P/FCF Ratio	-0.18	-0.47	-0.30	-1.45	-4.04	-18.18	Upgrade
P/OCF Ratio	-0.18	-0.47	-0.30	-1.45	-4.05	-18.29	Upgrade
EV/EBITDA Ratio	-0.09	-0.34	0.42	-1.04	-1.70	-15.00	Upgrade
EV/EBIT Ratio	-0.09	-0.34	0.42	-1.04	-1.70	-14.99	Upgrade
EV/FCF Ratio	-0.13	-0.45	0.61	-1.11	-2.19	-16.16	Upgrade
Debt / Equity Ratio	-0.05	-0.07	0.05	0.06	0.03	-	Upgrade
Debt / EBITDA Ratio	-0.01	-0.02	-0.03	-0.03	-0.05	-	Upgrade
Debt / FCF Ratio	-0.02	-0.02	-0.04	-0.03	-0.06	-	Upgrade
Quick Ratio	0.13	0.09	2.04	1.93	7.37	23.28	Upgrade
Current Ratio	0.26	0.26	2.55	2.88	8.13	25.38	Upgrade
Interest Coverage	-1163.73	-1364.54	-2172.64	-1560.14	-2896.63	-147.26	Upgrade
Return on Equity (ROE)	857.20%	33276.20%	-142.60%	-149.00%	-145.40%	-110.00%	Upgrade
Return on Assets (ROA)	-575.40%	-421.40%	-119.80%	-121.70%	-130.30%	-90.20%	Upgrade
Return on Capital (ROIC)	414.55%	456.64%	-178.71%	-221.13%	-65.72%	-50.43%	Upgrade
Earnings Yield	-5847.28%	-282.81%	-476.93%	-73.91%	-31.91%	-5.97%	Upgrade
FCF Yield	-4189.05%	-212.19%	-329.81%	-69.06%	-24.75%	-5.50%	Upgrade
Buyback Yield / Dilution	-357.00%	-176.66%	-55.02%	-58.58%	-21.76%	-29.86%	Upgrade
Total Shareholder Return	-357.00%	-176.66%	-55.02%	-58.58%	-21.76%	-29.86%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).